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Abstract
Triclocarban (3,4,49-trichlorocarbanilide, TCC) is used as a broad-based antimicrobial agent that is commonly added to
personal hygiene products. Because of its extensive use in the health care industry and resistance to degradation in sewage
treatment processes, TCC has become a significant waste product that is found in numerous environmental compartments
where humans and wildlife can be exposed. While TCC has been linked to a range of health and environmental effects, few
studies have been conducted linking exposure to TCC and induction of xenobiotic metabolism through regulation by
environmental sensors such as the nuclear xenobiotic receptors (XenoRs). To identify the ability of TCC to activate
xenobiotic sensors, we monitored XenoR activities in response to TCC treatment using luciferase-based reporter assays.
Among the XenoRs in the reporter screening assay, TCC promotes both constitutive androstane receptor (CAR) and
estrogen receptor alpha (ERa) activities. TCC treatment to hUGT1 mice resulted in induction of the UGT1A genes in liver. This
induction was dependent upon the constitutive active/androstane receptor (CAR) because no induction occurred in
hUGT1Car
2/2 mice. Induction of the UGT1A genes by TCC corresponded with induction of Cyp2b10, another CAR target
gene. TCC was demonstrated to be a phenobarbital-like activator of CAR in receptor-based assays. While it has been
suggested that TCC be classified as an endocrine disruptor, it activates ERa leading to induction of Cyp1b1 in female ovaries
as well as in promoter activity. Activation of ERa by TCC in receptor-based assays also promotes induction of human
CYP2B6. These observations demonstrate that TCC activates nuclear xenobiotic receptors CAR and ERa both in vivo and
in vitro and might have the potential to alter normal physiological homeostasis. Activation of these xenobiotic-sensing
receptors amplifies gene expression profiles that might represent a mechanistic base for potential human health effects
from exposure to TCC.
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Introduction
Triclocarban (3,4,49-trichlorocarbanilide, TCC), containing the
diphenyl urea moiety, is generally classified as a halogenated
aromatic hydrocarbon. Along with triclosan [5-chloro-2-(2,4-
dichlorophenoxy)phenol; TCS], TCC is used as a broad based
antimicrobial agent [1] that is commonly added to personal
hygiene products such as soaps and deodorants [2]. It has been
estimated that the antibacterial agent is present in 76% of all liquid
soaps, while TCC is the predominant antibacterial compound in
all soaps [3]. Up to 454,000 kg of TCC is used in the United States
each year [4]. As a result of its use in the health care industry and
its resistance to degradation in sewage treatment processes, TCC
has become a significant waste product that is found in numerous
environmental compartments, such as water resources, sewage and
sludge [4–6]. Evidence indicates that TCC passes freely through
wastewater treatment facilities into the effluent and accumulates in
the processed sludge, which is often used as a soil amendment or
fertilizer, thus allowing TCC to be reintroduced into the
environment. TCC has been detected at microgram per liter
levels in water compartments in the environment [7], and it is
among the top 10 most commonly detected organic waste water
compounds for frequency and concentration indicating extensive
contamination of aquatic systems [8,9]. Its ubiquitous distribution
in the environment has led to identification of TCC in biological
fluids both in wild animals and humans [10]. The use of TCC
containing soap products has demonstrated that TCC is readily
absorbed through the skin and can be detected in urine samples
following a single shower [11].
With the tendency of bioaccumulation in aquatic organisms
[12], TCC’s ubiquitous presence in the environment has raised
public concern regarding its potentially harmful effects in humans.
Recent studies using in vitro bioassay tools have shown that TCC
exhibits an association with various nuclear and steroid hormone
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have demonstrated that TCC can interfere with the Ah receptor
ligand binding by acting as an antagonist, and TCC can
synergistically enhance testosterone action through interaction
with the androgen receptor [10,13,14]. TCC evokes a modest
synergistic response with a cell-based estrogen receptor (ER)-
mediated bioassay in ERa positive human ovarian cancer cells
[10], but does not serve as a direct ligand. It has been suggested
that TCC be classified as an endocrine disruptor since it was
shown to synergize the enlargement of male sex accessory organs
in mice [13]. More recently, TCC has been shown to inhibit
soluble epoxide hydrolase (sEH), which could potentially lead to
biological regulation of inflammation, pain and blood pressure
[15]. These findings suggest that TCC has the potential to
influence human health.
Xenobiotic nuclear receptors (XenoRs) belong to a superfamily
of transcription factors that regulate genes involved in drug
metabolism and hormone homeostasis. Members of the XenoR
superfamily each contain a ligand-binding domain (LBD) and a
DNA binding domain (DBD) that targets the receptors to specific
DNA sequence in the regulatory regions of potential target genes
[16]. Upon ligand binding, the receptors translocate from the
cytoplasm to the nucleus and shift to a transcriptionally active
state, where they heterodimerize with the retinoic acid receptor
(RXR) and become functional transcription factors that activate
their target genes [17,18]. Considering their modulation by small
lipophilic molecules, we monitor activities of XenoRs, including
pregnane X receptor (PXR), constitutive active/androstane
receptor (CAR), liver X receptor alpha (LXRa), farnesoid X
receptor (FXR), vitamin D nuclear receptor (VDR), peroxisome
proliferator-activated receptor (PPARa), PPARb, PPARc,E R a,
and ERb, in response to TCC treatment. The initial study was to
screen this wide variety of XenoRs for interaction with TCC, thus
providing the framework for understanding the underlying
mechanism through which TCC modulates gene regulation. To
examine if TCC displayed CAR or PXR ligand specificity, we
elected to initially evaluate the impact of TCC treatment in
humanized UGT1 (hUGT1) mice [19]. The human UDP-glucur-
onosyltransferase 1 (UGT1) locus and the nine UGT1A genes are
expressed as a transgenic gene construct [20] in a Ugt1-null
background [21] and express each of the UGT1A genes in a tissue
specific fashion that is comparable to their expression patterns in
human tissues [22–25]. In liver, it has been demonstrated that
activation of PXR [20] and CAR [26] leads to induction of each of
the UGT1A genes. In addition, murine target genes activated by
PXR, such as Cyp3a11 and CAR which target induction of
Cyp2b10, can also be evaluated. Although TCC was shown
previously to have little ER agonist activity in receptor-based
bioassay screens [10], we elected to examine the impact of TCC
on Cyp1b1 expression in vivo in ERa sensitive tissues. Combined
with techniques employing reverse genetics in mice and mecha-
nistic studies in tissue culture, these findings add additional support
to the current body of literature that TCC is capable of altering
programmed gene expression, which may ultimately impact
human health.
Materials and Methods
Cells, Transfections, and Culture Conditions
a) XenoR screening assay: Nuclear receptors (i.e., PXR, CAR,
ERa, LXRa, VDR, FXR, PPARa, PPARd, PPARc, GR, and
RXR), expression plasmids, and the luciferase reporter constructs
containing their corresponding response elements were generated
as described previously [18,27–32]. CV-1 cells were maintained in
phenol-red free DMEM (Life Technologies) supplemented with
10% super-stripped FBS, seeded in 96-well plates, and transfected
with expression plasmids to supply a specific nuclear receptor (i.e.,
PXR, CAR, LXRa, VDR, FXR, PPARa, PPARd, PPARc,o r
GR) and RXR along with a luciferase reporter containing the
appropriate DNA response element. The assay was conducted
with TCC (10 mm) and various ligands as positive controls
including pregnenolone 16a-carbonitrile (PCN, 10 mM; Sigma)
for PXR, 1,4-Bis-[2-(3,5-dichloropyridyloxy)]benzene (TCPO-
BOP, 250 nM; Sigma) for CAR, b-estradiol (10 nM; Sigma) for
ER, T0901317 (1 mM; Cayman Chemical) for LXRa, calcipotriol
(10 mM; Sigma) for VDR, GW4064 (1 mM; Sigma) for FXR,
WY14643 (30 mM; Sigma) for PPARa, GW501516 (100 nM) for
PPARd, rosiglitazone (1 mM; Cayman Chemical) for PPARc,
dexamethasone (100 nM; Sigma) for GR to validate the process of
screening. b) ERa-mediated promoter activation: CV-1 cells were
transfected with luciferase vectors containing the 2-kb promoter
regions upstream of the start codon for CYP1B1 or CYP2B6 genes
(Switch Genomics, CA) and the pcDNA3.1 expression vector
alone or pcDNA3.1 expression vector for ERa. c) CAR ligand
binding assays: CV-1 cells were transiently transfected with the
expression vector containing the Gal4 DNA binding domain fused
with the ligand binding domain of murine or human CAR, and
co-transfected with the luciferase reporter plasmid, mh 100-luc
[16]. All the transfection experiments were carried out using
transient transfection reagent FugeneHD (Life Technologies) and
transfection efficiency was measured by co-transfection of a b-gal
expression vector. The day after the transfection, fresh phenol-red
free medium with super-stripped serum containing DMSO, the
positive compound of each nuclear receptor, or TCC (10 mM) was
added, and the cells were incubated for an additional 24 hours.
The luciferase activities were measured and normalized by b-gal
activity [33]. The human breast adenocarcinoma cell lines MCF-7
and MDA-MB-231 were cultured in DMEM (4.5 mg/L glucose)
supplemented with 10% fetal bovine serum (Invitrogen). Following
TCC treatments, cells were incubated for 24 hours and harvested
for total RNA isolation (Trizol, Invitrogen). Cell lines CV-1,
MCF7, and MDA-231 were purchased from American Type
Culture Collection (Manassas, VA).
Animals
Humanized UGT1 mice (hUGT1*28) were generated as
described previously [19]. The Car-null (Car
2/2) mouse line was
a generous gift from Dr. Negishi (National Institute of Environ-
mental Health Sciences, Research Triangle Park, NC). Genotyp-
ing for Car-null mice was described previously [34]. Humanized
UGT1*28 mice [19] were bred with Car
2/2 mice, and
hUGT1*28/Car
+/2 were backcrossed to produce hUGT1*28/
Car
2/2 mice. Ethics Statement: All animals received food
and water ad libitum, and mouse handling and experimental
procedures were conducted in accordance with our protocol
(approval ID: No. S99100), previously approved by the University
of California San Diego (UCSD) Institutional Animal Care and
Use Committee (IACUC). The IACUC oversees the UCSD
animal care and use program and is responsible for reviewing all
animal use protocols, ensuring compliance with the federal
regulations, inspecting animal facilities and laboratories and
overseeing training and educational programs.
In vivo Studies with hUGT1*28 and Car-null Mice
Age-matched groups of 6–8 week old animals were used, and
mice were treated intraperitoneally (i.p.) every 24 hours for 2 days
with Dimethyl Sulfoxide (DMSO) or TCC (16 mg/kg) dissolved in
50 ml DMSO for each injection. After 48 hours, the liver tissues,
TCC and Induction of UGT and CYP Genes
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e37705from each treatment group, were pulverized and used for
preparation of total RNA. For experiments to detect Cyp1b1 and
Cyp2b10 gene products in mouse ovary tissues, 10-day old female
mice were treated with TCC (20 mg/kg) or corn oil by i.p.
injection every other day for three weeks. Following the treatment,
ovary tissues were used to prepare total RNA.
Transfection of ERa-target Specific siRNA
Small interfering RNA (siRNA) duplexes were prepared by
Bioneer (Alameda, CA). Targeted coding regions of the ERa
oligonucleotides sequences were as follows iERa1, 59- CTG-
TCTTCTGTTGGGAACA -39, iERa2, 59-GTCACTACTCAG-
GCTGACT -39, and iERa3, 59- CACTGAAATGGCCATT-
GAT -39. MCF7 cells were seeded in a 6-well plate and transfected
in the presence of 10 nM of either siRNA or negative-control
RNA in a final volume of 1 ml OPTI-MEM with Lipofectamine
2000 (Invitrogen). After 5 hours, cells were replenished with fresh
medium containing 10% fetal bovine serum. The next day after
the transfection, cells were treated with either TCC or DMSO and
incubated for an additional 24 hours followed by total RNA
extraction. Real time RT-PCR results confirmed that transfection
with iERas reduced mRNA levels of ERa.
Real-time Reverse Transcription-PCR
Mouse CYP2B10, human UGT1A1, 1A3, 1A4, 1A6 and 1A9,
human CYP1B1 and human CYP2B6 mRNA levels were
quantitated by real-time RT-PCR. Total RNA was isolated and
cDNA was synthesized as described previously [35]. Following the
cDNA synthesis, real-time PCRs were conducted with a pair of
gene-specific primers and 2X MESA GREEN qPCR MasterMix
(Eurogentec, San Diego, CA) to determine a Ct value of the
corresponding gene using the MX4000 Multiplex Quantitative
PCR (Stratagene, La Jolla, CA). Briefly, one micro liter of the
cDNA template from the RT-PCR reaction was used in a 20 mlo f
reaction mixture containing 10 ml of 2X MESA Green qPCR
MasterMix and 0.4 mM of a pair of corresponding primers. The
forward and reverse primers for human CYP1B1 are (forward, 59-
TGACTGCCGTGTGTTTCGG -39, and reverse, 59-GTG-
CCTCAAGAACTTGTCCAG -39); for human CYP2B6 the
primers are (forward, 59- AGACGCCTTCAATCCTGACC,
and reverse, 59- CCTTCACCAAGACAAATCCGC -39), and
those for mouse Cyp2b10 and human UGT genes were described
previously [20]. Each sample was performed in triplicate,
normalized to the internal control genes mouse cyclophilin
(forward, 59- CAGACGCCACTGTCGCTTT -39, reverse, 59-
TGTCTTTGGAACTTTGTCTGCAA) or human b-actin (for-
ward, 59- GGCGGCACCACCATGTACCCT -39, and reverse,
59- AGGGGCCGGACTCGTCATACT -39), and quantified
based on the formula DCt = Ct
(tested gene) –C t
(cyclophilin).
Microsomal Protein Preparation and Immunoblot
Analysis
Age-matched mice were treated with either DMSO or TCC by
i.p. injection for 48 hours. Following exposure by chemical
treatment, mice were sacrificed and the microsomal fraction from
mouse liver tissues was prepared as described previously [36]. The
extracted microsomal protein (30 mg) was loaded on pre-cast Bis-
Tris gel (NuPAGE, Novex) and electrophoresis was performed
following determination of protein concentrations. The resolved
protein was transferred onto a nitrocellulose membrane, and the
membrane blocking, incubation with the primary antibody
CYP2B10 (a kind gift from Dr. Negishi, NIEHS) and horseradish
peroxidase-conjugated secondary antibody (Cell Signaling) were
described previously [36]. Protein was detected by Renaissance
Western Blot chemiluminescence reagent (PerkinElmer Life
Sciences) and visualized using Bio-Rad ChemiDoc imager.
Reagents
TCC, 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP),
and DMSO were from Sigma-Aldrich. (6-(4-Chlorophenyl)imi-
dazo[2,1-b] [1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzy-
l)oxime) (CITCO) was from Tocris Bioscience (St. Louis, USA).
The Bradford assay for protein concentration analysis was from
Bio-Rad Laboratories. The dual-luciferase reporter assay system
and reporter plasmid, pGL3-basic vector and pRL-SV40 vector
were from Promega. The plasmids for CAR ligand binding assay
and CAR-mediated promoter activation was described previously
[37]. The expression vector for ERa (pcDNA-ERa) was
constructed in house (Evans Lab).
Statistics
The values in the table and figures correspond to the mean 6
standard deviation (SD) of at least three samples. Student’s t-test
was used to assess differences between groups. Statistically
significant differences are indicated with *, p,0.05; **, p,0.005;
***, p,0.0005.
Results
TCC Activates CAR and ERa
a) XenoR screening: Of the 11 XenoRs screened with TCC
at the concentration of 10 mM, ERa and CAR were effectively
activated by TCC (Table 1). CAR was moderately activated by
TCC with 1.75-fold induction of luciferase activity. TCC also
promotes ERa activity with similar potency as estradiol (Table 1).
All other nuclear receptors produce statistically insignificant
induction with VDR, FXR, PPARc, and GR being mostly
unaffected, thus TCC likely only has minimal effects on these
receptors. b) ERa-mediated promoter activation: It has been
shown previously that the human CYP1B1 gene is regulated by
estradiol through the ERa [38]. The ERa receptor has also been
reported to regulate the expression of the human CYP2B6 gene
[39]. To identify the potential role of ERa in gene induction for
CYP1B1 and CYP2B6 by exposure to TCC, transient transfections
with a luciferase vector containing the 2kb fragment upstream
from the CYP2B6 start site (pGL3–2B6) with or without co-
transfection of ERa were performed. The reporter activity of
pGL3–2B6 increased with TCC treatment in a dose-dependent
manner to a level compatible to that of estradiol treatment in the
presence of ERa (Figure 1A). To further support the role of ERa
in TCC-mediated gene regulation, gene expression of human
CYP1B1, a well-characterized enzyme that is linked to expression
in estrogen-regulated tissue through ERa [38] was examined.
Similar to the CYP2B6 response to TCC, CYP1B1 promoter
activity was significantly induced by TCC in a dose-dependent
fashion. Mimicking the estradiol action, ERa is required for the
CYP1B1 promoter activation by TCC (Figure 1B). c) CAR ligand
binding assay: CAR has been shown to display a species
divergence in ligand specificity. Human CAR (hCAR), but not
murine CAR (mCAR), is strongly activated by CITCO, but the
mouse receptor is more sensitive to TCPOBOP than hCAR [40].
We further conducted transfection experiments using a fusion
protein containing the mCAR ligand-binding domain and the
Gal4 DNA-binding domain along with a Gal4 responsive
luciferase reporter, mh100, showed no change in luciferase
expression levels to TCC, while TCPOBOP elicited a robust
induction as a positive control. Similarly, hCAR exhibited no
TCC and Induction of UGT and CYP Genes
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2B) suggesting that TCC is a CAR activator, but not an agonist
ligand for either mouse or human CAR.
TCC Induction of Xenobiotic Metabolism by CAR
The UGT1A genes expressed in hUGT1*28 mice are susceptible
to regulation by CAR [26], PXR [20], peroxisome proliferator-
activated receptor-alpha (PPARa) [41] and the Ah receptor [20].
Initial experiments were conducted by treating hUGT1*28 mice
with 16 mg/kg TCC by the i.p. route and evaluating UGT1A gene
expression patterns in liver after 48 hours. In comparison to
DMSO treated mice, UGT1A1, 21A3, 21A4, 21A6, and 21A9
gene products were each induced in hUGT1*28 mice following
TCC administration (Figure 3). When gene targets that are
regulated by CAR (Cyp2b10), PXR (Cyp3a11), PPARa (Cyp4a11)
and the Ah receptor (Cyp1a1) were evaluated by real time RT-
PCR analysis, only Cyp2b10 gene expression was found to be
induced (Figure 4), indicating that CAR activation by TCC was
leading to the induction of the UGT1A genes. To examine if CAR
was underlying the induction pattern, we treated hUGT1*28/
Car
2/2 mice with TCC and examined expression of the UGT1A
genes. In comparison to hUGT1*28 mice, there was no induction
of the UGT1A genes in hUGT1*28/Car
2/2 mice. This correlated
with a nearly complete absence of Cyp2b10 gene induction
following TCC treatment in hUGT1*28/Car
2/2 mice
(Figure 4A). To access the expression of Cyp2b10 protein in
microsomal preparation from treated mouse livers, Western blot
analysis was performed with antibody against the CYP2B6
protein. Consistent with the transcript levels, Cyp2b10 protein
expression was induced by TCC treatment, and the induction was
blocked in Car
2/2 livers (Figure 4B).
CYP2B6 and CYP1B1 Gene Expression Regulated by TCC
To investigate the effect of TCC on CYP2B6 mRNA expression
through a ERa-dependent mechanism, ERa positive MCF7 and
ERa negative MDA-MB-231 human breast cancer cells were
treated with TCC. Results of real time RT-PCR revealed dose-
and time-dependent effects of TCC treatment on induction of
CYP2B6 mRNA expression in ERa positive MCF7 cells
(Figure 5A). In contrast, CYP2B6 expression was unaffected in
TCC-treated ERa negative MDA-MB-231 cells. To further
support the role of ERa in TCC-mediated gene regulation, gene
expression of human CYP1B1, a well-characterized enzyme that is
linked to expression in estrogen-regulated tissue through ERa [38]
was examined. Similar to CYP2B6 response to TCC, MCF7 cells
exhibited a TCC-dependent increase in CYP1B1 mRNA levels
that was not observed in MDA-MB-231 cells, further assuring the
involvement of ERa in TCC-mediated gene induction (Figure 5B).
Furthermore, we examined mouse Cyp1b1 induction in ERa
sensitive tissue such as the ovaries. TCC treatment to female
hUGT1*28 mice resulted in the induction of Cyp1b1 (Figure 5C).
These results clearly link TCC exposure to activation of ERa
target genes, Cyp1b1/CYP1B1 and Cyp2b10/CYP2B6 in both
cultured human breast cancer cells and in vivo estrogen-sensitive
tissues. Finally, transfection experiments with siRNAs targeting
ERa were performed to interrupt ERa gene expression in MCF7
cells. Gene expression levels for CYP1B1, CYP2B6, and ERa were
analyzed by real time PCR following siRNA transfections and
TCC treatment. SiRNA knockdown of ERa with 58% effective-
ness significantly reduced CYP1B1 and CYP2B6 gene expression in
MCF7 cells (Figure 6), further assuring the involvement of ERa in
TCC-mediated gene induction.
Discussion
With the XenoR screening assay, our results show divergent
receptor binding activities of TCC as indicated by fold induction
of luciferase activity. This system appears to be a suitable
qualitative model for evaluating XenoR activation toward tested
compounds. CAR and ERa appeared most susceptible to TCC
activation and exhibited moderate luciferase activity. We then
assessed potential biological effects arising from TCC exposure in
the perspective of drug and steroid metabolism and discussed the
molecular mechanism through which the key phase I and phase II
xenobiotic metabolizing enzymes are induced. The use of in vitro
cell-based assays to predict and define the underlying mechanisms
Table 1. Xenobiotic receptors screening assay.
Xenobiotic receptors Reporter constructs
Fold induction in the
absence of ligand
Fold induction with the
positive ligand Fold induction with TCC
Era ERE 160.1 2.8960.26 2.1360.14**
Erb ERE 160.06 1.8560.26 1.4760.15
CAR PBRE 160.07 2.0560.33 1.7560.30***
PXR CYP3A promoter 160.27 4.2260.73 1.4460.44
LXRa LXRE 160.4 2.3461.49 1.5160.73
VDR CYP24A1 promoter 160.45 9.6763.94 1.0660.07
FXR FXRE 160.14 29.363.79 0.8860.18
PPARa PPRE 160.13 8.662.89 1.5360.27
PPARd PPRE 160.32 10.3660.64 1.5760.55
PPARc PPRE 160.32 5.8960.64 1.0360.55
GR GRE 160.1 5.8362.17 1.160.18
TCC was tested for the ability to activate PXR, CAR, LXRa, FXR, VDR, PPARa, PPARb, PPARc,E R a,a n dE R b by binding to the corresponding response element. CV1 cells
were transfected with an expression plasmid to supply a human nuclear receptor, a luciferase reporter plasmid containing the appropriate DNA response element, and
a b-galactosidase expression vector to control for transfection efficiency. The positive ligand for each receptor is described in Material and Method. Luciferase activity
was represented as fold induction relative to DMSO-treated cells. The results are expressed as the mean 6 S.D.
**p,0.005.
***p,0.0005, significant difference between the values for DMSO- and TCC-treated wells.
doi:10.1371/journal.pone.0037705.t001
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useful approach to understand xenobiotic interactions caused by
TCC. An indirect interaction of TCC with CAR that enables
TCC to induce the human UGT1A genes in hUGT1*28 mice was
revealed in our animal models. The specificity of CAR-mediated
regulation by TCC is supported by observations that hepatic
Cyp2b10 is also induced, while the UGT1A genes and the Cyp2b10
gene are not induced in hUGT1*28/Car
2/2 mice. We also
eliminated any interaction with PXR, since PXR was insensitive to
TCC in the luciferase reporter assay, and TCC has no effect on
expression of the PXR-target gene Cyp3a11 (data not shown).
CAR is well recognized to regulate the induction of the CYP2B
genes by PB and a group of diverse agents referred to as ‘‘PB-like’’
agents including the pesticide contaminant TCPOBOP, the most
potent PB-like inducers known in rodents [42]. To date, only a few
CAR agonists, such as TCPOBOP for murine CAR and CITCO
for human CAR are identified. Our results with the GAL4-
human/mouse CAR LBD fusion proteins, representing the ligand
specificity of CAR, indicate that TCC, mimicking PB, acts as an
indirect CAR activator. Although the luciferase activation by TCC
was at a moderate level, this induction was significant compared to
that of the control and 2-fold induction by TCPOBOP. The
moderate scale CAR activation in the luciferase screening assay by
TCC may be due to the unique feature of CAR being a
constitutive active receptor even in the absence of an exogenous
ligand as well as being a CAR activator through an indirect
mechanism that facilitates translocation of CAR to the nucleus
and transactivation of its target genes.
The ability of TCC to stimulate CAR target genes may be of
significance. The current study has demonstrated cross-regulation
with CYP2B and human UGT1A genes by TCC through CAR
activation. This is not surprising because a PB response element
flanking the gene promoter has been identified in both human
CYP2B6 and UGT1A1 genes [37,39]. It is well characterized that
the CAR-mediated inducible expression of xenobiotic-metaboliz-
ing enzymes and accelerated metabolic elimination of correspond-
ing substrates is associated with drug-drug interaction clinically. In
addition, CAR can act as a negative regulator controlling
Figure 1. Promoter Activation by TCC. Transfection of a Luc reporter containing the 2 kb CYP2B6 (A) or CYP1B1 (B) promoter region with or
without cotransfection of an ERa expression vector to CV-1 cells was performed. Following transfection, cells were treated for 24 hours with DMSO or
different concentrations of TCC as indicated. Firefly luciferase activity was measured and normalized by using the level of b-galactosidase activity.
doi:10.1371/journal.pone.0037705.g001
Figure 2. CAR ligand binding assay. HepG2 cells were transfected with the expression vector containing the Gal4 DNA binding domain fused
with the ligand binding domain of murine CAR (mCAR, A) or human CAR (hCAR, B), and cotransfected with the Luciferase reporter plasmid, mh 100-
luc. Following transfection, cells were treated for 24 hours with phenobarbital (1 mM), TCC (10 mM), TCPOBOP (25 mM), or CITGO (10 mM). Firefly
Luciferase activity was measured and normalized by using the level of renilla luciferase activity.
doi:10.1371/journal.pone.0037705.g002
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[35,43]. This down regulation might lead to changes in steady-
state dynamics of steroids and bile acid homeostasis. Thus, TCC
contamination in biological systems may be critically relevant by
interfering with metabolism of endogenous and exogenous
substrates by CAR-target xenobiotic genes. For example, a recent
study has linked CAR pre-activation and alcohol infusion to a
synergistic decrease in the expression of enzymes that metabolize
the alcohol in liver including alcohol dehydrogenase 1, aldehyde
dehyrogenase (ALDH) 1A1, ALDH3A2, and CYP2E1, which
supports the role of CAR in modulating alcoholic liver injury [44].
Secondly, it has been characterized that PB-like agents possess
CAR-dependent liver enlargement properties that are evidenced
by increases in cell proliferation and suppression of apoptosis [45].
This CAR-dependent action is thought to be a prerequisite and
underlying mechanism for nongenotoxic PB-mediated liver
tumorigenesis [46]. Therefore, TCC might deserve close scrutiny
to determine if its long-term effects on liver disease and
tumorigenesis through a CAR dependent mechanism, similar to
the actions of PB.
While transcriptional regulation of the CYP2B gene is evident
through TCC-mediated CAR activation, the slight induction of
Cyp2b10 in TCC-treated CAR null livers (1.77–3.26 fold induction
compared with DMSO-treated ones) implies the CAR-indepen-
dent mechanism. Recently, a study has confirmed ERa-dependent
regulation of CYP2B6, in which a functional ER response element
was identified in the CYP2B6 regulatory region [39]. In this study,
we provide compelling evidence showing CYP2B6 induction by
TCC is also mediated through ERa. In addition to CAR, TCC
enables induction of CYP2B6 promoter activity in an ERa-
dependent fashion. Moreover, ERa activation by TCC affects
other ERa target genes; CYP1B1 transcription is subjected to ERa-
dependent TCC regulation as evidenced by activation of the
CYP1B1 promoter region, which was previously characterized as
harboring a functional ERa binding site [38]. TCC-mediated
induction of CYP2B6 and CYP1B1 was observed in estrogen
sensitive cultured cells and tissues further supporting the observa-
tion that TCC exposure can regulate target genes of ERa through
an ERa-dependent mechanism.
Human TCC metabolism involves direct N2 and N9-
glucuronidation and ring hydroxylation to 2-OH-TCC and 6-
OH-TCC, which can further undergo sulfate and glucuronide
conjugation [47]. TCC metabolites are detected in plasma and
urine in subjects who have showered with TCC-containing soap
with TCC-N-glucuronides as the major route of renal excretion
[11]. The robust TCC-mediated CYP2B gene induction through
both CAR and ERa activation may be relevant considering that
contact to TCC maybe occurring consistently over time through
Figure 3. The comparative expression of hepatic UGT1A genes between hUGT1 and hUGT1/Car
2/2 mice. RT-PCR analysis using liver
RNA from DMSO- or TCC-treated (16 mg/kg, dissolved in 50 ml DMSO) mice and isoform specific-primer pairs was performed to detect the expression
of UGT1A genes as indicated.
doi:10.1371/journal.pone.0037705.g003
TCC and Induction of UGT and CYP Genes
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e37705the use of personal care products. CYP2B6 is one of the major
enzymes to metabolize clinical drugs (e.g., cyclophosphamide and
tamoxifen), and 202 to 250-fold inter-individual variation in
CYP2B6 expression has been demonstrated [48], presumably due
to transcriptional regulation and polymorphisms. Environmental
exposure to agents like TCC may be contributing towards
variation in CYP2B6 since both CAR and ERa are regulators of
this gene and potential targets following TCC exposure.
With environmentally relevant concentrations, a recent report
indicated that TCC increased embryo production in the
freshwater mud snail suggesting that TCC may be causing
reproductive effects in a manner similar to that seen with some
known environmental estrogens [49]. Although TCC is not an
agonist for the AR (androgen receptor), TCC has the ability to
amplify the effect of testosterone on the androgenic activity in the
AR-mediated luciferase assay [13]. To study ER interactions, Ahn
et al. [10,14] performed a cell-based ER-mediated bioassay to
study TCC-ERa interaction. At 1 and 10 mM, TCC evoked a
modest response equivalent to about 30% of that produced by
1 nM estradiol. Although it is a mild agonist for the ERa in the
reporter gene assay, TCC enhances the estrogen action in the
presence of estrogen [10]. Combined with our results, it can be
anticipated that TCC has a significant influence on modulating
transcriptional control of ERa target genes, such as those involved
in xenobiotic and steroid metabolism. For example, regulating
CYP1B1 gene expression by TCC reinforces its ability to disrupt
estrogen homeostasis. Estrogen has long been associated with
breast cancer. CYP1B1 is highly expressed in estrogen target
tissues and changes in the expression of proteins such as CYP1B1
are known to metabolize estrogens, which can potentially alter
physiological levels and the intensity of estrogen action. In
addition, CYP1B1 catalyzes the 4-hydroxylation of estradiol to
Figure 4. Cyp2b10 gene expression following the TCC treatment. Age-matched heterozygous (CAR
+/2) and Car-null mice (Car
2/2)( n=3 )
were treated with either DMSO or TCC (16 mg/kg) by intraperitoneal injection for 48 hours. A. The liver tissues were used for preparation of total
RNA. After the reverse transcription for cDNA synthesis, real-time PCR was conducted to determine the Ct value with cyclophilin as an internal control
gene. B. The microsomal proteins were prepared from liver tissues and subject to Western Blot analysis using Cyp2b10 antibody as the primary
antibody.
doi:10.1371/journal.pone.0037705.g004
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produces free radicals, causes cellular damage, and is associated
with carcinogenic activity of estrogen and the development of
breast cancer. The continual use of personal care products that
contain antimicrobial agents like TCC may enhance over time the
generation of endogenously produced metabolites capable of
eliciting a toxic or carcinogenic episode. In addition, CAR
activation has recently been shown to inhibit human UGT2B7
gene expression [35]; indicating that continued exposure to TCC
would have a negative influence on normal drug metabolism and
clearance. Combined with evidence that there is considerable
cross-talk between the ER and CAR [51,52], TCC accumulation
may surely influence the many target genes involved in xenobiotic
metabolism. Therefore, the perceived benefits of using TCC as an
antimicrobial agent in personal care products should be weighed
against possible risks.
In Conclusion
These studies demonstrate that acute exposure to TCC results
in the activation of important regulatory pathways dictated by
CAR and ERa that can potentially impact the steady-state levels
of hormones, as well as altering routes of drug metabolism. One of
the important check points in steroid homeostasis is biological
inactivation by glucuronidation, which is shown in this study to be
induced in a CAR dependent fashion following TCC treatment.
Induction of cytochrome P450 genes, whose products are steroid
hydroxylases, is also regulated by TCC both through CAR as well
as ERa. Combined with findings that TCC is capable of
synergizing the actions of testosterone through the AR [13], these
studies suggest that long term exposure to TCC, from daily use of
personal hygiene products, has the potential of altering normal
steroid biogenesis. Thus, long term alterations in hormone
homeostasis initiated by chronic exposure to TCC could
potentially lead to human health problems.
Figure 5. Activation of gene expression by TCC. Human breast cancer cell lines, MCF7 and MDA-MB-231, were cultured and treated with either
DMSO or 5 or 10 mM TCC. Following total RNA isolation and reverse transcription reaction, CYP2B6 (A) or CYP1B1 (B) mRNA levels were measured by
real-time PCR using a gene specific pair of primers. (C) Induction of cyp1b1 gene in mouse ovary and fallopian tube by TCC. 10-day old
hUGT1*28 mice were treated with corn oil or TCC (20 mg/kg) by i.p. injection every 48 hours until 30 days of age. The tissues of ovaries and fallopian
tubes were used to prepare total RNA. Following the reverse transcription for cDNA synthesis, real-time PCR was conducted to determine the Ct value
for cyp1b1 with cyclophilin as an internal control gene.
doi:10.1371/journal.pone.0037705.g005
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